Literature DB >> 1936525

Insulin activation of rat prolactin promoter activity.

C A Keech1, A Gutierrez-Hartmann.   

Abstract

The role of insulin regulation of rat prolactin (rPRL) gene transcription was studied using GH4 rat pituitary tumor cells transiently transfected with plasmids containing proximal rPRL promoter fragments ligated to the reporter gene luciferase. Here we show that insulin, at nanomolar concentrations, has a rapid effect on the rPRL promoter stimulating its activity about 1.8-fold within 4h after hormone addition. Furthermore, we have mapped the rPRL promoter element responsible for mediating insulin hormone action between positions -212 and +73. The stimulation of rPRL gene transcription by insulin was abolished when insulin doses extended into the micromolar range. Thus, rPRL promoter sequences downstream of -212 are sufficient to mediate increased rPRL gene transcription in response to insulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936525     DOI: 10.1016/0303-7207(91)90185-u

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  Interaction of basal positive and negative transcription elements controls repression of the proximal rat prolactin promoter in nonpituitary cells.

Authors:  S M Jackson; C A Keech; D J Williamson; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain.

Authors:  A P Bradford; K E Conrad; C Wasylyk; B Wasylyk; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.

Authors:  K E Conrad; J M Oberwetter; R Vaillancourt; G L Johnson; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.